NR3C2 and type 2 diabetes mellitus: Drugs that are considered to have an effect on renal function were more widely prescribed in type 2 diabetes such as ACEi (22.9 vs. 10.2 %), ARBs (14.0 vs. 6.2 %), mineralocorticoid receptor antagonists ([MRAs] 2.5 vs. 0.5 %) and SGLT-2is (9.0 vs. 1.0 %).